Live Breaking News & Updates on Theodora harold

Stay informed with the latest breaking news from Theodora harold on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Theodora harold and stay connected to the pulse of your community

Crescendo Biologics presents preclinical data on lead clinical candidate CB307 and unveils its first '2 in 1' immune cell engager CB699 at AACR 2024

Crescendo Biologics presents preclinical data on lead clinical candidate CB307 and unveils its first '2 in 1' immune cell engager CB699 at AACR 2024
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

United-kingdom , London , City-of , Cambridge , Cambridgeshire , United-states , American , David-daley , Mary-jane-elliott , Sukaina-virji , Theodora-harold , Regius-professor-of-cancer-research

Crescendo Biologics announces first U.S. patients dosed in expanded Phase 1b clinical trial of CB307 for patients with mCRPC

Crescendo Biologics announces first U.S. patients dosed in expanded Phase 1b clinical trial of CB307 for patients with mCRPC
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

Cambridge , Cambridgeshire , United-kingdom , Spain , Netherlands , Theodora-harold , David-daley , Mary-jane-elliott , Ip-group , Linkedin , University-of-washington , Crescendo-biologics-ltd

Crescendo widens pivotal solid tumour therapy trial

Crescendo widens pivotal solid tumour therapy trial
pharmatimes.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pharmatimes.com Daily Mail and Mail on Sunday newspapers.

Sonia-benhamida , Theodora-harold , Ip-group-biontech , Andera-partners , Sofinnova-partners , Quan-capital , Kreos-capital , Crescendo-biologics ,

IP : Crescendo Biologics - Secures $32M and announces expansion of CB307 Phase 1b trial in PSMA+ solid tumours

24 Jul 2023

$32 million additional capital raised, supported by all major existing investors and new investor Kreos Capital

...

United-kingdom , Cambridge , Cambridgeshire , Theodora-harold , Melanie-toyne-sewell-adam-loudon , Sonia-benhamida , Crescendo-biologics-ltd , Zai-lab , Ip-group-biontech , Ip-group , Kreos-capital , Biologics-ltd

Crescendo Biologics secures $32M and announces expansion of CB307 Phase 1b trial in PSMA+ solid tumours

Crescendo Biologics secures $32M and announces expansion of CB307 Phase 1b trial in PSMA+ solid tumours
financialcontent.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from financialcontent.com Daily Mail and Mail on Sunday newspapers.

United-kingdom , Cambridge , Cambridgeshire , Theodora-harold , Sonia-benhamida , Crescendo-biologics-ltd , Ip-group-biontech , Linkedin , Ip-group , Zai-lab , Kreos-capital , Biologics-ltd

BioNTech : and Crescendo Biologics announce global collaboration to develop multi-specific precision immunotherapies - Form 6-K

BioNTech and Crescendo Biologics announce global collaboration to develop multi-specific precision immunotherapies

•Collaboration leverages BioNTech's... | January 10, 2022

United-states , Cambridge , Cambridgeshire , United-kingdom , Melanie-toyne-sewell , Nathan-billis , Theodora-harold , Fosun-pharma , Sylke-maas , Katie-duffell , Michael-booth , Ugur-sahin

IP Group plc (via Public) / Crescendo Biologics Ltd - BioNTech and Crescendo Biologics announce global collaboration to develop multi-specific precision immunotherapies

IP Group plc (via Public) / Crescendo Biologics Ltd - BioNTech and Crescendo Biologics announce global collaboration to develop multi-specific precision immunotherapies
publicnow.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from publicnow.com Daily Mail and Mail on Sunday newspapers.

Cambridge , Cambridgeshire , United-kingdom , Theodora-harold , Ugur-sahin , Fosun-pharma , Genentech , Zai-lab , Bayer-animal-health , Pfizer , Ip-group , Cancer-research-united-kingdom

Crescendo Biologics Announces That Zai Lab Has Achieved Proof-of-Concept for ZL-1102 (Humabody, CB001) in a Phase 1b Clinical Trial in Psoriasis Patients

Crescendo Biologics Announces That Zai Lab Has Achieved Proof-of-Concept for ZL-1102 (Humabody, CB001) in a Phase 1b Clinical Trial in Psoriasis Patients
financialbuzz.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from financialbuzz.com Daily Mail and Mail on Sunday newspapers.

Cambridge , Cambridgeshire , United-kingdom , Katie-duffell , Melanie-toyne-sewell , Michael-booth , Nathan-billis , Theodora-harold , Zai-lab-to-crescendo , Ip-group , Cancer-research-united-kingdom , Zai-lab

Synairgen plc: Non-Executive Director Appointment

Synairgen plc('Synairgen' or the 'Company') Non-Executive Director Appointment Southampton, UK - 30 September 2021: Synairgen plc (LSE: SNG), the drug discovery, development and commercialisation

United-kingdom , Cambridge , Cambridgeshire , Mary-conway , Richard-marsden , John-ward , Duncan-monteith , Jessica-hodgson , Ratko-djukanovic , Simon-shaw , Freddie-barnfield , Professorsir-stephen-holgate

Non-Executive Director Appointment

Synairgen plc(‘Synairgen’ or the ‘Company’) Non-Executive Director Appointment Southampton, UK – 30 September 2021: Synairgen plc (LSE: SNG), the drug...

United-kingdom , Cambridge , Cambridgeshire , Mary-conway , Richard-marsden , John-ward , Duncan-monteith , Jessica-hodgson , Ratko-djukanovic , Simon-shaw , Freddie-barnfield , Professorsir-stephen-holgate